Literature DB >> 25679115

Development and testing psychometric properties of an ICF-based health measure: The Neuromuscular Disease Impact Profile.

Isaäc Bos1, Jan B M Kuks, Klaske Wynia.   

Abstract

OBJECTIVES: To develop a measure that is based on the International Classification of Functioning, Disability and Health (ICF) and reflects the prevalence and severity of disabilities related to neuromuscular disorders, and to evaluate the psychometric properties of this measure.
METHODS: A preliminary questionnaire was developed, based on the categories of the ICF Core Set for Neuromuscular Diseases. Next a cross-sectional postal survey was carried out among 702 patients (70% response rate) diagnosed with a neuromuscular disease. Finally, psychometric properties were examined.
RESULTS: The preliminary Neuromuscular Disease Impact Profile (NMDIP) consisted of 45 items. Factor analysis showed that the NMDIP comprised domains representing 3 ICF-components: 5 factors in the Body Functions component, 2 factors in the Activities component, and 1 factor in the Participation component. Scales showed moderate to good internal consistency (α = 0.63-0.92) and mean inter-item correlation coefficients (0.38-0.77). Convergent and discriminant validity analysis indicated that the NMDIP measures the impact of neuromuscular disease on physical, mental, and social functioning. The NMDIP discriminates between groups who differ in extent of limitations.
CONCLUSION: The NMDIP is an ICF-based measure that reflects neuromuscular disease-related disabilities. It consists of 36 items divided over 8 scales with satisfactory psychometric properties and 4 single items.

Entities:  

Mesh:

Year:  2015        PMID: 25679115     DOI: 10.2340/16501977-1938

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  6 in total

1.  Application of the International Classification of Functioning, Disability and Health system to symptoms of the Duchenne and Becker muscular dystrophies.

Authors:  Kristin M Conway; Emma Ciafaloni; Dennis Matthews; Chris Westfield; Kathy James; Pangaja Paramsothy; Paul A Romitti
Journal:  Disabil Rehabil       Date:  2017-04-11       Impact factor: 3.033

2.  Stability and relative validity of the Neuromuscular Disease Impact Profile (NMDIP).

Authors:  Isaäc Bos; Jan B M Kuks; Josué Almansa; Hubertus P H Kremer; Klaske Wynia
Journal:  BMC Neurol       Date:  2017-05-11       Impact factor: 2.474

3.  Care for capabilities: Implementing the capability approach in rehabilitation of patients with neuromuscular diseases. Study protocol of the controlled before-after ReCap-NMD study.

Authors:  Bart Bloemen; Eirlys Pijpers; Edith Cup; Jan Groothuis; Baziel van Engelen; Gert Jan van der Wilt
Journal:  PLoS One       Date:  2021-12-21       Impact factor: 3.240

Review 4.  An Overview of Mitochondrial Protein Defects in Neuromuscular Diseases.

Authors:  Federica Marra; Paola Lunetti; Rosita Curcio; Francesco Massimo Lasorsa; Loredana Capobianco; Vito Porcelli; Vincenza Dolce; Giuseppe Fiermonte; Pasquale Scarcia
Journal:  Biomolecules       Date:  2021-11-04

5.  Operationalization of the Brief ICF Core Set for Hearing Loss: An ICF-Based e-Intake Tool in Clinical Otology and Audiology Practice.

Authors:  Lisette M van Leeuwen; Marieke Pronk; Paul Merkus; S Theo Goverts; Caroline B Terwee; Sophia E Kramer
Journal:  Ear Hear       Date:  2020 Nov/Dec       Impact factor: 3.562

6.  Management of motor rehabilitation in individuals with muscular dystrophies. 1st Consensus Conference report from UILDM - Italian Muscular Dystrophy Association (Rome, January 25-26, 2019).

Authors:  Maria Elena Lombardo; Elena Carraro; Cristina Sancricca; Michela Armando; Michela Catteruccia; Elena Mazzone; Giulia Ricci; Ferdinando Salamino; Filippo Maria Santorelli; Massimiliano Filosto
Journal:  Acta Myol       Date:  2021-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.